Latest Breaking News On - Sun rock - Page 12 : comparemela.com

(1) NANJING, China, Feb. 22, 2021 /PRNewswire/ On February 21, 2021, GenScript ProBio and SunRock Biopharma, a company focused on the development of antibody therapeutics targeting cancer, announced a collaboration spanning preclinical discovery to large scale GMP manufacturing for SunRock s CCR9 therapeutic antibody candidates. GenScript ProBio will provide SunRock Biopharma a one-stop-solution from antibody discovery, cell line development, process development to GMP drug substance and drug product manufacturing services. By leveraging complementary strengths and capabilities, the parties are committed to the R&D, manufacturing process development, NMPA, FDA & EMA IND filings of CCR9 therapeutic antibodies, towards rapid development of novel antibody therapeutics. CCR9 is a novel therapeutic target expressed in highly aggressive cancer. It is associated with increased metastatic potential and tumor-chemoresistance. This program will enable new treatment formats with innovative

Sunrock biopharmaJuan buelaGenscript probioGenscript biotech corporation stock codeScript probioGeneral managerThrough collaborationBrian minGenscript biotech corporationStock codeSun rockBio pharmaஜநரல் மேலாளர்மூலம் இணைந்துபிரையன் நிமிடம்ஸ்டாக் குறியீடு